Vivex Biologics

Vivex develops and delivers innovative allografts designed to support the body’s healing potential to help improve patient outcomes and quality of life. Our medical technologies date back 50 years to the founding of The University of Miami Tissue Bank in 1970.

Since that time, we have experienced multiple firsts in clinical and scientific achievements. Vivex’s strategic plan is focused on the development of new innovative allografts, research and development, enhancement of manufacturing capabilities, and sales and marketing efforts.